• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Expert Rev Vaccines . Global impact of delta plus variant and vaccination

tetano

Editor, Senior Moderator
Expert Rev Vaccines


. 2022 Feb 19.
doi: 10.1080/14760584.2022.2044800. Online ahead of print.
Global impact of delta plus variant and vaccination


Vivek P Chavda[SUP] 1 [/SUP], Vasso Apostolopoulos[SUP] 2 [/SUP]



Affiliations

Abstract

The "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" variant strains identified in India consist of three main lineages ("double mutant" variant): Kappa variant, Delta variant, and B.1.618. It is believed that the delta variant lacks the 484K/Q mutation, which has now been related to vaccination resistance. Currently, 63 Delta variant genomes with the K417N mutation were recognized by the GISAID. Delta plus variant (AY.1 variant or B.1.617.2.1) is the modified version of the delta variant which has brought a devastating second COVID-19 wave in India and it has been declared as a "variant of concern (VOC)" by the World Health Organization. As of 28th November 2021, more than 500 cases of delta plus variant have been reported in 12 countries, in particular in the US, UK, and India.

Keywords: COVID-19; Delta Plus Variant; Delta Variant; Omicron; SARS-CoV-2; Spike mutations.
 
Back
Top Bottom